FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to cardiosurgery and beam diagnostics, and can be used for assessing degree of haemodynamic disorders in the Ebstein anomaly. It involves echocardiography in B-mode and colour Doppler mapping. Apical four-chamber position is fixed from an apex point of the right ventricle at the beginning of ventricular systole. Obtained image is used to measure the shortest distance in mm from the level of the fibrous ring of the tricuspid valve to the apex of the right ventricular cavity (I) and to measure the shortest distance from the level of the fibrous ring of the tricuspid valve until the beginning of the regurgitation jet corresponding to the level of closure of valve flaps (A). Hemodynamic disorder index is determined in the Ebstein anomaly (HDI)=A/I. If the HDI value is less than 0.25, a disorder of delamination of the posterior and septal valve cusps is stated, which corresponds to the state of the patient with degree 1, wherein the operation is not required or is performed at the age of more than 10 years. If the HDI value is 0.26–0.5, the disruption of delineation of the posterior and septal flaps of the tricuspid valve is stated, which corresponds to the state of the patient with degree 2, wherein the operation is performed at age of 5–10 years. If the HDI value is 0.51–0.75, a disorder of delineation of the posterior, septal and anterior flaps of the tricuspid valve is stated, which corresponds to the state of the patient with degree 3, wherein the operation is performed at age of 1–5 years. If the HDI value is 0.76–1.0, a disorder of delineation of the posterior, septal and anterior flaps of the tricuspid and posterior and anterior flaps of the mitral valves is stated, which corresponds to the state of the patient suffering degree 4, where urgent surgery is required.
EFFECT: technical result provides a more reliable and repeatable method of assessing the state of a child with an Ebstein anomaly, which will allow predicting the length and need for the surgical intervention.
1 cl, 1 dwg, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF RECONSTRUCTION OF THREE-LIQUID VALVE UNDER EBSTEIN ANOMALY OF TYPE D | 2017 |
|
RU2672382C1 |
METHOD OF SURGICAL CORRECTION OF EBSTEIN ABNORMALITY | 2018 |
|
RU2702468C1 |
METHOD OF SURGICAL CORRECTION OF EBSTEIN ABNORMALITY | 2019 |
|
RU2721820C1 |
CARDIOVASCULAR HOMOGRAFT (VERSIONS), METHOD FOR PREPARING HOMOGRAFT, HOMOGRAFT TISSUE EXPOSURE MEDIUM (VERSIONS) | 2013 |
|
RU2525197C1 |
METHOD FOR PROSTHETIC VALVE IMPLANTATION IN TRICUSPID POSITION | 2011 |
|
RU2465834C1 |
METHOD ASSESSING CARDIOVASCULAR SYSTEM STATE FOLLOWING SURGICAL INTERVENTION | 2011 |
|
RU2479247C1 |
METHOD FOR SURGICAL MANAGEMENT OF HEART DEFECTS BY OPERATION OF FONTAN AND HOMOGRAFT FOR IMPLEMENTATION THEREOF | 2017 |
|
RU2700127C2 |
METHOD FOR PROSTHETICS OF A TRICUSPIDAL VALVE IN PATIENTS WITH INFECTIOUS ENDOCARDITIMS | 2017 |
|
RU2645634C1 |
METHOD FOR SETTING TRICUSPID VALVE PROSTHESIS IN CASES OF EBSTEIN ANOMALY | 1995 |
|
RU2130286C1 |
METHOD FOR DETERMINATION OF HEART RIGHT VENTRICLE EJECTION FRACTION | 2016 |
|
RU2613427C1 |
Authors
Dates
2019-09-05—Published
2017-07-12—Filed